Quinocarcin
Quinocarcin (DC-52) is a potent antitumor antibiotic. Quinocarcin inhibits Bacillus subtilis DNA, RNA and protein syntheses.
For research use only. We do not sell to patients.
- CAS No.: 84573-33-1
- Formula: C18H22N2O4
- Molecular Weight:330.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Antibiotic Isoforms
More
Biological Activity
Quinocarcin (100 µg/mM; 0-20 min) inhibits Bacillus subtilis DNA, RNA and protein syntheses[1].
Quinocarcin (0.1, 1, 10 mM) interactes with PM2 DNA in a dose-dependent manner[1].
Quinocarcin (0-100 µM) shows cell cytotoxicity with LC50 values of >100, 3.18, 3.83, 0.49, 84.85, 43.27 µM for LOX-IMVI; SK-MEL-5, UACC-62, UACC-257, MALME-3M cells, respectively[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LOX-IMVI; SK-MEL-5, UACC-62, UACC-257, MALME-3M cells
-
Concentration:0-100 µM
-
Incubation Time:
-
Result:Showed cell cycotoxicity with 50% cytotoxicity (LC50) values of >100, 3.18, 3.83, 0.49, 84.85, 43.27 µM for LOX-IMVI; SK-MEL-5, UACC-62, UACC-257, MALME-3M cells, respectively.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice (SK-MEL-2 tumors) [3]
-
Dosage:40 mg/kg
-
Administration:I.p.; on days 14, 21, and 28
-
Result:Inhibited tumor growth by 89%.
Chemical Information
-
CAS No. 84573-33-1
-
Molecular Weight 330.38
-
Formula C18H22N2O4
-
SMILES
O=C(O)[C@@H]1[C@]2([C@]([H])(N3[C@@]4(CO[C@]3([C@@]([H])(C1)N2C)[H])[H])CC5=C4C(OC)=CC=C5)[H]
-
Synonyms
Quinocarmycin; DC-52; KW2152 free base
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Tomita F, et al. Quinocarcin, a novel antitumor antibiotic. 3. Mode of action. J Antibiot (Tokyo). 1984 Oct;37(10):1268-72. [Content Brief]
[2]. Kahsai AW, et al. Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44. Chem Biol. 2006 Sep;13(9):973-83. [Content Brief]
[3]. Plowman J, et al. Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice. Cancer Res. 1995 Feb 15;55(4):862-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Quinocarcin Related Classifications
HY-129292 Related Classifications
Powered by Bioz